🚫U.S. Trade Commission Issues Exclusion Order for Pharmaceutical Violations
Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 of the Tariff Act of 1930, as amended, in the above-captioned investigation by respondents Ascletis Pharma Inc. of Hangzhou, Zhejiang Province, China; Ascletis Pharmaceuticals Co. Ltd. of Shaoxing, Zhejiang Province, China; Ascletis Bioscience Co., Ltd. of Hangzhou, Zhejiang Province, China; and Gannex Pharma Co., Ltd. of Shanghai, China (collectively, "Corporate Respondents"), based on their misappropriation of certain asserted trade secrets. The Commission has determined to issue a seven-year limited exclusion order ("LEO") prohibiting the unlicensed entry into the United States of certain selective thyroid hormone receptor-beta agonists, processes for manufacturing or relating to same, and products containing same, imported by or on behalf of the Corporate Respondents, and a cease and desist order ("CDO") against each of the Corporate Respondents. The investigation is terminated.
Learn More🔧Limited Exclusion Order on Injection Molding Components
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order ("LEO") barring entry of certain components for injection molding machines, and products containing the same by or on behalf of respondent Ningbo AO Sheng Mold Co., Ltd., d/b/a AOSIMI ("AOSIMI") previously found to be in default. The investigation is terminated.
Learn More🚫General Exclusion Order on Tirzepatide
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a general exclusion order ("GEO") prohibiting the importation of products containing tirzepatide and products purporting to contain tirzepatide that infringe U.S. Trademark No. 6,809,369 or include a false designation of origin; a limited exclusion order ("LEO") prohibiting the entry of falsely advertised products containing tirzepatide and products purporting to contain tirzepatide that are imported by or on behalf of certain defaulting respondents; and cease and desist orders ("CDOs") directed against certain defaulting respondents. This investigation is terminated.
Learn More🚫Limited Exclusion Order on Eye Cosmetics
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order ("LEO") barring entry of certain eye cosmetics and packaging therefor that are imported by or on behalf of the following respondents previously found in default: Kaibeauty of Taipei City, Taiwan; I'll Global Co., Ltd of Seoul, South Korea; Hikari Laboratories, Ltd. of Bnei Atarot, Israel; and Kelz Beauty of Budapest, Hungary (collectively, "the Defaulting Respondents"). The investigation is terminated.
Learn More⚖️ITC Issues Limited Exclusion Order on Liquid Transfer Devices
Notice is hereby given that the U.S. International Trade Commission has determined to affirm the determination finding a violation of section 337 of the Tariff Act of 1930, as amended, in the remand initial determination ("Remand ID") issued by the Chief Administrative Law Judge ("CALJ") and to take no position with respect to a portion of the Remand ID. The Commission has also determined to issue a limited exclusion order prohibiting further importation of infringing products by the three remaining respondents and a cease and desist order against one respondent.
Learn More📦Commission Notice on Rescission Proceeding for Plastic Food Trays
Notice is hereby given that the U.S. International Trade Commission has determined to institute a rescission proceeding and to temporarily suspend enforcement of a limited exclusion order ("LEO") issued in the underlying investigation.
Learn More